Sign in

CIK 0001527753

  • Non-accelerated filer
  • Smaller reporting company

Personalis, Inc.

Sign in to watch
Ticker
PSNL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275411038
Phone
+1 650-752-1300
Business address
6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
  1. 4 Option exercise President and CEO acquired 10,000 shares (option exercise)
  2. 4 Open-market sale Chief Financial Officer sold 4,360 shares at $2.60 ($11,336)
  3. 4 Open-market sale Chief Medical Officer sold 440 shares at $2.60 ($1,144)
  4. 4 Open-market sale Chief Medical Officer sold 1,295 shares at $2.71 ($3,509)
  5. 4 Open-market sale General Counsel sold 2,045 shares at $2.71 ($5,542)
  6. 4 Open-market sale Chief Financial Officer sold 1,294 shares at $2.71 ($3,507)
  7. 4 Open-market sale Chief Medical Officer sold 1,581 shares at $3.48 ($5,502)
  8. 4 Open-market sale Chief Financial Officer sold 3,474 shares at $3.48 ($12,090)
  9. 4 Open-market sale Chief Medical Officer sold 420 shares at $3.33 ($1,399)
  10. 4 Open-market sale Chief Financial Officer sold 4,168 shares at $3.33 ($13,879)
  11. 4 Grant or award General Counsel acquired 18,600 shares (grant or award)
  12. 4 Grant or award General Counsel acquired 18,600 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award President and CEO acquired 230,000 shares (grant or award)
  16. 4 Grant or award Director acquired 30,940 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Medical Officer sold 632 shares at $3.91 ($2,471)
  19. 4 Open-market sale Chief Financial Officer sold 632 shares at $3.91 ($2,471)
  20. 4 Open-market sale Chief Medical Officer sold 1,565 shares at $3.29 ($5,149)

Page 7 of 15 · 289 filings